Clinical Trials Browser

Phase 1/2 × Urinary Bladder Neoplasms × derazantinib × Clear all

NCT04045613 2023-10-13

FIDES-02

Phase 1/2 Completed

95 enrolled 25 charts

Acrocephalosyndactylia, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell